Sunshine Biopharma Inc (SBFM)

[kingbee]

Waiting patiently through the last quiet period here. Things to expect before April-

After 25 days Aegis can issue buy recommendations to their clients. Our stock has a market cap less than the cash on hand. Any way you slice it, this stock is way undervalued.

After the quiet period imposed on Sunshine is over, expect to hear that both PL4 and Adva are moving to Fast Track application and IND studies. I know this is happening because the company already told us this in the filings.

The mice studies for PL4 were a success. The mice studies for Adva were a success. This I know from the filings.

I also expect another appraisal this year reaffirming the billion + value for both drugs.

I expect to win here. Win or lose though, I think the next 6 weeks will tell the story. For that I will be grateful.